- Manda Ratcliff
- Eric Schafer
The Waisman Center through the University of Wisconsin, Madison offers the Wiley Seminar Series throughout the academic year. The Wiley Seminar Series connects researchers who are nationally and internationally known for their work on developmental and neurodegenerative diseases to the interprofessional and multi-disciplinary audience of clinicians interested in these topics. The Wiley Seminar occurs most Fridays from September-April at 12pm. Presentations are followed by a Q/A.
Healthcare providers and researchers with a special interest in the area of developmental/genetic medicine including but not limited to: Primary Care Physicians (MD and MD/PhD), physician specialists, physician assistants (MPAS), nurse practitioners (RN/MS/DNP), occupational therapists (MS/OTD), physical therapists (MS/DPT), speech-language pathologist (MS/PhD), psychologists (PhD/PsyD), Dietitians (MS/PhD), social workers (BSW/MSW/PhD), trainees, and clinic coordinators.
|Maria Stanley, MD, Chair
|Manda Ratcliff, Coordinator
|Hayley Crain, PsyD
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
Participants will be able to:
- Increase knowledge of the etiology of neurodevelopmental diseases/disorders and the scientific evidence influencing recent advances in developmental/genetic medicine in order to recognize trends and how they might impact patient care.
- Improve ability to consistently identify evidence-based medical practices and to apply this knowledge to team-based care for patients with developmental disabilities.